LOGIN  |  REGISTER
Assertio
Amneal Pharmaceuticals

MultiPlan Makes Fortune’s Best Workplaces in Health Care List for Second Year in a Row

September 12, 2024 | Last Trade: US$6.01 0.66 -9.90

NEW YORK / Sep 12, 2024 / Business Wire / MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, is honored to announce it has been named in the 2024 Fortune Best Workplaces in Health Care™ List. based on its 2023-2024 Great Place to Work® Certification™ results. This is the second time MultiPlan has been named in the Best Workplaces in Health Care list. Earning a spot means that MultiPlan is one of the best companies to work for in the country.

The Best Workplaces in Health Care list is based on analysis of survey responses from over 185,000 employees from Great Place To Work Certified™ companies in the health care industry. Survey responses reflect a comprehensive picture of the workplace experience by current employees.

MultiPlan employees scored the company particularly high in areas of justice, community, and leadership. This ranking is based on last year’s Great Place To Work score where 87% of employees declared MultiPlan a great place to work.

“There is nothing more important to us than being the best place to work for our people,” said Carol Nutter, Chief People Officer at MultiPlan. “This prestigious achievement reflects our organization's strong team culture and deep commitment to the role we play in the healthcare industry and to each other."

“Fortune congratulates the Best Workplaces in Health Care,” says Fortune Editor-in-Chief Alyson Shontell. “Creating a vibrant workplace culture that draws the best talent in health care is vital for the success of the leaders in this highly competitive industry. It is also what’s needed to ignite innovation and deliver best-in-class performance.”

The Best Workplaces in Health Care list is highly competitive. Great Place To Work, the global authority on workplace culture, determines its lists using its proprietary For All™ Methodology to evaluate and certify thousands of organizations in America’s largest ongoing annual workforce study, based on over 1.3 million survey responses and data from companies representing more than 8.2 million employees this year alone.

“Congratulations to the Best Workplaces in Health Care,” says Michael C. Bush, CEO of Great Place To Work. “These companies not only outperform the average for their industry but have created workplaces that outshine the average in every category, proving the importance of building trust with workers, no matter the industry.”

This prestigious award follows MultiPlan’s announcement of the third consecutive year the company has been certified by Great Place To Work and second consecutive year being named to Fortune’s 2023 Best Workplace in New York List.

Looking to grow your health care career at a great workplace? Visit the careers page on multiplan.com to learn more about MultiPlan and how to join our team.

About MultiPlan

MultiPlan is committed to bending the cost curve in healthcare by delivering transparency, fairness, and affordability to the US healthcare system. Our focus is on identifying medical savings, helping to lower out-of- pocket costs, and reducing or eliminating balance billing for healthcare consumers. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets customers’ needs and customizes innovative solutions that combine its payment and revenue integrity, network-based, data and decision science, and analytics-based services. MultiPlan delivers value to more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit multiplan.com.

About the Fortune Best Workplaces in Health Care List

Great Place To Work selected the 2024 Fortune Best Workplaces in Health Care by analyzing confidential survey responses from more than 1.3 million employees, representing the experiences of more than 8.2 million employees in 2023 and 2024. Of those responses, more than 185,000 were from employees at Great Place To Work Certified companies in the health care industry, and this ranking is based on that feedback. Company rankings are derived from 60 employee experience questions within the Great Place To Work Trust Index™ Survey. Companies with 10 to 999 employees competed in the small and medium category. Companies with 1,000 or more employees were considered for the large category.

About Great Place To Work

As the global authority on workplace culture, Great Place To Work brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Its proprietary platform and Great Place To Work Model help companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified and receiving recognition on a coveted Best Workplaces™ List.

About Fortune

Fortune upholds a legacy of award-winning writing and trusted reporting for executives who want to make business better. Independently owned, with a global perspective and digital agility, Fortune tells the stories of a new generation of innovators, builders, and risk takers. Online and in print, Fortune measures corporate performance through rigorous benchmarks and holds companies accountable. Fortune creates communities by convening true thought leaders and iconoclasts — those who shape industry, commerce, and society – through powerful and prestigious lists, events, and conferences, such as the iconic Fortune 500, the CEO Initiative, and Most Powerful Women. For more information, visit fortune.com.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB